Skip to main content
Log in

Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. De Las PR, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Alvarez Y, Rodriguez CA, Virizuela JA, Lopez lopez R (2016) SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 24:499–507

    Article  Google Scholar 

  2. Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec’h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF (2013) Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care 17:R12

    Article  PubMed  PubMed Central  Google Scholar 

  3. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 40:320–331

    Article  PubMed  Google Scholar 

  4. Beck LH (1979) Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 301:528–530

    Article  CAS  PubMed  Google Scholar 

  5. Dorhout Mees EJ, Blom van Assendelft P, Nieuwenhuis MG (1971) Elevation of uric acid clearance caused by inappropriate antidiuretic hormone secretion. Acta Medica Scandinavica 189:69–72

    Article  CAS  PubMed  Google Scholar 

  6. Castillo JJ, Vincent M, Justice E (2012) Diagnosis and management of hyponatremia in cancer patients. Oncologist 17:756–765

    Article  PubMed  PubMed Central  Google Scholar 

  7. Darmon M, Pichon M, Schwebel C, Ruckly S, Adrie C, Haouache H, Azoulay E, Bouadma L, Clec’h C, Garrouste-Orgeas M, Souweine B, Goldgran-Toledano D, Khallel H, Argaud L, Dumenil AS, Jamali S, Allaouchiche B, Zeni F, Timsit JF (2014) Influence of early dysnatremia correction on survival of critically ill patients. Shock 41:394–399

    Article  PubMed  Google Scholar 

  8. Rondon-Berrios H, Berl T (2015) Mild chronic hyponatremia in the ambulatory setting: significance and management. Clin J Am Soc Nephrol: CJASN 10:2268–2278

    Article  CAS  PubMed  Google Scholar 

  9. Berl T (2015) Vasopressin antagonists. N Engl J Med 372:2207–2216

    Article  CAS  PubMed  Google Scholar 

  10. Gankam Kengne F, Couturier BS, Soupart A, Decaux G (2015) Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline. Kidney Int 87:323–331

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to François Vincent.

Additional information

GrrrOH: Groupe de recherche en réanimation respiratoire en Onco-Hématologie (Group for Research in Respiratory Intensive Care Onco-Hematology; http://www.grrroh.com/)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vincent, F., Ayed, S., Bouguerba, A. et al. Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans. Support Care Cancer 24, 3685–3686 (2016). https://doi.org/10.1007/s00520-016-3178-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3178-2

Keywords

Navigation